Transporters in drug development: 2018 ITC recommendations for transporters of emerging clinical importance

MJ Zamek‐Gliszczynski, ME Taub… - Clinical …, 2018 - Wiley Online Library
This white paper provides updated International Transporter Consortium (ITC)
recommendations on transporters that are important in drug development following the 3rd …

Renal drug transporters and drug interactions

A Ivanyuk, F Livio, J Biollaz, T Buclin - Clinical pharmacokinetics, 2017 - Springer
Transporters in proximal renal tubules contribute to the disposition of numerous drugs.
Furthermore, the molecular mechanisms of tubular secretion have been progressively …

Clinical probes and endogenous biomarkers as substrates for transporter drug‐drug interaction evaluation: perspectives from the international transporter consortium

X Chu, M Liao, H Shen, K Yoshida… - Clinical …, 2018 - Wiley Online Library
Drug transporters can govern the absorption, distribution, metabolism, and excretion of
substrate drugs and endogenous substances. Investigations to examine their potential …

Transporters involved in metformin pharmacokinetics and treatment response

X Liang, KM Giacomini - Journal of pharmaceutical sciences, 2017 - Elsevier
Metformin, widely used as first-line treatment for type 2 diabetes, exists primarily as a
hydrophilic cation at physiological pHs. As such, membrane transporters play a substantial …

Clinical aspects of transporter‐mediated drug–drug interactions

A Gessner, J König, MF Fromm - Clinical Pharmacology & …, 2019 - Wiley Online Library
Drug transporters play an essential role in disposition and effects of multiple drugs. Plasma
concentrations of the victim drug can be modified by drug–drug interactions occurring in …

Advancing Predictions of Tissue and Intracellular Drug Concentrations Using In Vitro, Imaging and Physiologically Based Pharmacokinetic Modeling Approaches

Y Guo, X Chu, NJ Parrott, KLR Brouwer… - Clinical …, 2018 - Wiley Online Library
This white paper examines recent progress, applications, and challenges in predicting
unbound and total tissue and intra/subcellular drug concentrations using in vitro and …

Update on drug-drug interaction at organic cation transporters: mechanisms, clinical impact, and proposal for advanced in vitro testing

H Koepsell - Expert Opinion on Drug Metabolism & Toxicology, 2021 - Taylor & Francis
Introduction: Organic cation transporters collectively called OCTs belong to three gene
families (SLC22A1 OCT1, SLC22A2 OCT2, SLC22A3 OCT3, SLC22A4 OCTN1, SLC22A5 …

Metabolomic and genome‐wide association studies reveal potential endogenous biomarkers for OATP1B1

SW Yee, MM Giacomini, CH Hsueh… - Clinical …, 2016 - Wiley Online Library
Transporter‐mediated drug‐drug interactions (DDIs) are a major cause of drug toxicities.
Using published genome‐wide association studies (GWAS) of the human metabolome, we …

Evaluation of transporters in drug development: current status and contemporary issues

SC Lee, V Arya, X Yang, DA Volpe, L Zhang - Advanced Drug Delivery …, 2017 - Elsevier
Transporters govern the access of molecules to cells or their exit from cells, thereby
controlling the overall distribution of drugs to their intracellular site of action. Clinically …

The complexities of interpreting reversible elevated serum creatinine levels in drug development: does a correlation with inhibition of renal transporters exist?

X Chu, K Bleasby, GH Chan, I Nunes, R Evers - Drug Metabolism and …, 2016 - ASPET
In humans, creatinine is formed by a multistep process in liver and muscle and eliminated
via the kidney by a combination of glomerular filtration and active transport. Based on …